Immunotherapy in colorectal cancer: Statuses and strategies
Colorectal cancer (CRC) is widely recognized as the third most prevalent malignancy globally and the second leading cause of cancer-related mortality. Traditional treatment modalities for CRC, including surgery, chemotherapy, and radiotherapy, can be utilized either individually or in combination. H...
Saved in:
Main Authors: | Yuan Li, Zewei Cheng, Shengli Li, Jiwei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Heliyon |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024173859 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancements in cellular immunotherapy: overcoming resistance in lung and colorectal cancer
by: Lijuan Qin, et al.
Published: (2025-02-01) -
New insight in immunotherapy and combine therapy in colorectal cancer
by: Kai Ji, et al.
Published: (2025-01-01) -
The role of ferroptosis in colorectal cancer and its potential synergy with immunotherapy
by: Wenhua Xia, et al.
Published: (2025-01-01) -
Research trends on immunotherapy for colorectal cancer: A bibliometric analysis
by: HaoNan Kang, et al.
Published: (2025-02-01) -
Improving ferroptosis-mediated immunotherapy for colorectal cancer through lysosome-targeted photodynamic therapy
by: Zhian Chen, et al.
Published: (2025-04-01)